All Podcasts – Johns Hopkins Medicine Podcasts

If you’re a woman going through menopause you may have chosen to go online for help. If so you may be the victim of a ‘femtech’ company. Wen Shen, a menopause expert at Johns Hopkins, explains. Shen: Basically they're there …

What is a ‘femtech’ company? Elizabeth Tracey reports Read More »

 Women may be experiencing overmedicalization as they transition through menopause, a recent Lancet series seems to suggest. Wen Shen, a menopause expert at Johns Hopkins, says that’s not her experience, since she sees many women who avoid physicians until symptoms …

Where does the perception that menopause is overmedicalized come from? Elizabeth Tracey reports Read More »

A recent Lancet series on menopause may result in many more women turning to the internet for help. That’s according to Wen Shen, a menopause expert at Johns Hopkins, who fears the series may have set back progress on bringing …

Women in menopause often go online for help, Elizabeth Tracey reports Read More »

As women transition through menopause, they should be offered conservative approaches that don’t rely on medicines. That’s one interpretation of a recent Lancet series on menopause, and Wen Shen, a menopause expert at Johns Hopkins, says while such an approach …

Can menopause symptoms be managed easily for most? Elizabeth Tracey reports Read More »

Is menopause overmedicalized? That seems to be one conclusion of a recent series published in the Lancet on this life stage for women. Wen Shen, a menopause expert at Johns Hopkins, begs to disagree. Shen: It's unfortunate that they came …

A new series on menopause in a major journal does a disservice, Elizabeth Tracey reports Read More »

An injectable drug called omalizumab now may be used to manage severe food allergies, the FDA has decided. Robert Wood, an allergy expert at Johns Hopkins, says the drug will only work if people are taking it. Wood: This is …

Is lifelong treatment necessary with a drug to manage severe food allergies? Elizabeth Tracey reports Read More »

Omalizumab is an injectable drug just approved by the FDA to treat severe food allergies. Robert Wood, one author of a study used to inform the agency’s decision and an allergy expert at Johns Hopkins, says risks discerned in the …

Are there downsides to using omalizumab for treating food allergy? Elizabeth Tracey reports Read More »

Consequences of food allergies can be life-threatening, which is why FDA approval of omalizumab to treat them is welcome. Robert Wood, one author of a study used to inform the agency’s decision and an allergy expert at Johns Hopkins, says …

Are food allergies becoming more common? Elizabeth Tracey reports Read More »

Feeding very young children peanut products can assure that they don’t develop an allergy to peanut. Can this strategy be expanded to allergies to foods like milk, meat, or egg? Johns Hopkins allergy expert Robert Wood comments. Wood:  There’s an enormous …

Can early feeding of allergenic foods overcome them? Elizabeth Tracey reports Read More »

Can food allergies be outgrown? Elizabeth Tracey reports Most people know about peanut allergy, since it impacts a lot of people, especially children. Can these allergies be outgrown? Robert Wood, an allergy expert at Johns Hopkins, says for most, that’s …

Hnf040124 Read More »